A call for global harmonization of phase I oncology trials: Results from two parallel, first in-human phase I studies of DS-7423, an oral PI3K/mTOR dual inhibitor in advanced solid tumors conducted in the United States and Japan Meeting Abstract

  

Authors:	Yokota, T.; Bendell, J. C.; LoRusso, P.; Tsushima, T.; Desai, V.; Kenmotsu, H.; Watanabe, J.; Ono, A.; Murugesan, B. G.; Silva, J.; Naito, T.; Greenberg, J.; Kumar, P.; Wang, Y.; Jikoh, T.; Shiga, R.; Ho, A. L.; Gounder, M. M.
Abstract Title:	A call for global harmonization of phase I oncology trials: Results from two parallel, first in-human phase I studies of DS-7423, an oral PI3K/mTOR dual inhibitor in advanced solid tumors conducted in the United States and Japan
Meeting Title:	53rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	35
Issue:	15 Suppl.
Meeting Dates:	2017 Jun 2-6
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2017-05-20
Start Page:	116s
Language:	English
ACCESSION:	WOS:000411895704139
DOI:	10.1200/JCO.2017.35.15_suppl.2536
PROVIDER:	wos
Notes:	Meeting Abstract: 2536 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/147316